Quijano, Asher Edrian .

HRN: 21-15-86  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/15/2022
MUPIROCIN 2%, 15G (TUBE)
05/15/2022
05/21/2022
TOPICAL
2% Ointment
2x A Day For 7 Days
IV Site Infection
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: